Alnylam Pharmaceuticals, Inc. (BVMF:A1LN34)
Brazil · Delayed Price · Currency is BRL 124.80
+3.20 (2.63%)
At close: Dec 3, 2025
Alnylam Pharmaceuticals Market Cap
Alnylam Pharmaceuticals has a market cap or net worth of 331.6 billion as of December 4, 2025. Its market cap has increased by 88.29% in one year.
Market Cap
331.60B
Enterprise Value
331.86B
Revenue
17.11B
Ranking
n/a
PE Ratio
1,428.23
Stock Price
124.80
Market Cap Chart
Since May 28, 2004, Alnylam Pharmaceuticals's market cap has increased from 361.82M to 331.60B, an increase of 91,548.24%. That is a compound annual growth rate of 37.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 3, 2025 | 331.60B | 76.65% |
| Dec 31, 2024 | 187.71B | 61.05% |
| Dec 29, 2023 | 116.56B | -24.59% |
| Dec 30, 2022 | 154.57B | 36.78% |
| Dec 31, 2021 | 113.01B | 44.11% |
| Dec 31, 2020 | 78.42B | 51.93% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rede D'Or São Luiz | 101.09B |
| Raia Drogasil | 41.21B |
| Hypera | 16.96B |
| Fleury | 8.28B |
| Odontoprev | 6.42B |
| Diagnósticos da América | 4.31B |
| Empreendimentos Pague Menos | 4.01B |
| Blau Farmacêutica | 2.32B |